CIK 0001806540
Lycia Therapeutics, Inc.
Sign in to watch- Ticker
- LYCA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- other
- EIN
- 843860514
- Phone
- (650) 392-3357
- Business address
- 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $38,522,394
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,522,394. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +8,305 | $26.95 | $224K | 6,858,542 |
| 2026-10-30 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +8,804 | $26.27 | $231K | 6,850,037 |
| 2026-10-30 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +200 | $26.86 | $5K | 6,850,237 |
| 2026-10-29 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +1,000 | $26.33 | $26K | 6,841,233 |
| 2026-10-28 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +10,570 | $25.23 | $267K | 6,835,803 |
| 2026-10-28 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +4,430 | $25.97 | $115K | 6,840,233 |
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +8,729 | $25.84 | $226K | 6,794,166 |
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +31,067 | $26.84 | $834K | 6,825,233 |
| 2026-10-26 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Conversion | +4,779,793 | 4,832,732 | ||
| 2026-10-26 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +1,944,444 | $18.00 | $35.0M | 6,777,176 |
| 2026-10-26 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +8,261 | $26.97 | $223K | 6,785,437 |
| 2026-10-26 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Conversion · Series C Preferred Stock | −17,142,578 | 0 | ||
| 2026-10-26 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Conversion · Series D Preferred Stock | −4,408,091 | 0 | ||
| 2026-10-23 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +24,560 | $25.68 | $631K | 24,560 |
| 2026-10-23 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +28,379 | $26.11 | $741K | 52,939 |
Page 1 of 1 · 15 trades